Medical Condition News

RSS

Study offers new evidence on how childhood immunometabolic risk factors may lead to depression, psychosis

A growing body of research suggests that early-life infection, inflammation, and metabolic changes could contribute to psychiatric disorders – perhaps via effects during critical periods of brain development.

11 Jan 2022

Phase 1 clinical trial shows the safety, feasibility of CAR-M cell therapy for solid tumors

Preliminary findings from Penn Medicine in an ongoing first-in-human clinical trial examining the safety, tolerability and feasibility of chimeric antigen receptor macrophage (CAR-M) has helped to establish the viability of this innovative immunotherapy, which advances the trailblazing scientific discovery of CAR T cell therapy- also pioneered at Penn- for solid cancer tumors and offers a promising new strategy in the fight against cancer.

11 Jan 2022

New study identifies ways to detect COPD in low- and middle-income countries

How to better detect chronic obstructive pulmonary disease (COPD) in low- and middle-income countries is a question that has long plagued the global medical community.

11 Jan 2022

Impact of post-exposure BNT162b2 prophylaxis against SARS-CoV-2 infections

In a new study, researchers determined evidence for post-exposure vaccination in reducing the mortality rate of COVID-19 and concluded that post-exposure prophylaxis successfully decreased SARS-CoV-2-associated death rates.

11 Jan 2022

Developing a 'fingerprint' test that could diagnose Alzheimer’s early

In this interview, we spoke to Dr. Cynthia McMurray about her latest research into Alzheimer's disease.

11 Jan 2022

COVID-19 symptoms found to vary in different immune contexts

In a new study, researchers studied the kinetics of host response to SARS-CoV-2 infection in a Syrian hamster model, tracking disease pathology, viral loads, antibody responses, and inflammatory cytokine production in multiple organs.

11 Jan 2022

Ketamine plus psychological therapy can help people stay off alcohol for longer time

People with severe alcohol disorder were able to stay off alcohol for longer when they were treated with low doses of ketamine combined with psychological therapy in a clinical trial.

11 Jan 2022

Secondhand nicotine vaping at home may increase risk of bronchitic symptoms in young adults

Secondhand exposure at home to the nicotine vapour from e-cigarettes is linked to a heightened risk of bronchitic symptoms and shortness of breath among young adults, finds research published online in the respiratory journal Thorax.

11 Jan 2022

Psychotropic drugs are commonly used by patients with heart disease, study shows

Antidepressants and other psychiatric medications are associated with an almost doubled risk of premature death in patients with heart conditions, according to research published today in the European Journal of Cardiovascular Nursing, a journal of the European Society of Cardiology (ESC).

11 Jan 2022

Neurologist receives ERC grant to study novel light-activated drugs with antiepileptic effects

Dr. Michael Wenzel from the Department of Epileptology at the University Hospital Bonn has received a coveted Starting Grant from the European Research Council.

10 Jan 2022

Poor cognition may be part of normality in older age, research says

At the first sign of cognitive trouble, people often worry Alzheimer's disease is forthcoming. But poor cognition can be part of the spectrum of normality in older age, according to new research published in JNeurosci.

10 Jan 2022

Research may lead to new treatment options for Crohn's disease patients

Results of a new study by researchers at Case Western Reserve University represent a step toward improving our understanding of Crohn's disease and the factors that cause its intestinal inflammation.

10 Jan 2022

Improving air quality may reduce dementia risk in older women

Improving air quality appears to slow cognitive decline and reduce the risk of developing dementia in older women living in the U.S., according to a new study by researchers from the Keck School of Medicine of USC.

10 Jan 2022

Researchers illuminate the molecular landscape and clinical features of rare kidney cancer

Translocation renal cell carcinoma (tRCC) is a rare and aggressive form of kidney cancer. It accounts for about 5 percent of all renal cell carcinomas in adults and about 50 percent in children.

10 Jan 2022

Higher olive oil consumption linked with lower risk of cardiovascular disease, cancer mortality

Consuming more than 7 grams (>1/2 tablespoon) of olive oil per day is associated with lower risk of cardiovascular disease mortality, cancer mortality, neurodegenerative disease mortality and respiratory disease mortality, according to a study publishing today in the Journal of the American College of Cardiology.

10 Jan 2022

New grant program launches to advance therapeutic discovery for follicular lymphoma

Today saw the launch of a dedicated grant program aimed at advancing therapeutic discovery for follicular lymphoma (FL), The Follicular Lymphoma Foundation (FLF) CURE FL Awards - Curative Research to Eliminate Follicular Lymphoma.

10 Jan 2022

NCCN publishes new guidelines for managing patients with Graft-Versus-Host Disease

The National Comprehensive Cancer Network today announced the publication of new NCCN Guidelines for Patients: Graft-Versus-Host Disease (GVHD).

10 Jan 2022

Scientists shine new light on the complexity of vitamin B12 diseases

A team of researchers at Baylor College of Medicine and collaborating institutions has shed new light into the complexity of vitamin B12 diseases.

10 Jan 2022

JPND announces call for multinational research on understanding the mechanisms of non-pharmacological interventions

The EU Joint Programme - Neurodegenerative Disease Research (JPND) initiative has announced a joint transnational call for multinational research on understanding the mechanisms of non-pharmacological interventions.

10 Jan 2022

Mapping regulatory T-cell populations in COVID-19 patients

In a new study, researchers used mass spectrometry to investigate changes to immune systems, in particular regulatory T-cells (Tregs), in a large cohort of moderate, severe, and critical Japanese coronavirus disease 2019 (COVID-19) patients and healthy controls.

10 Jan 2022

Medical Condition News

Study offers new evidence on how childhood immunometabolic risk factors may lead to depression, psychosis

Phase 1 clinical trial shows the safety, feasibility of CAR-M cell therapy for solid tumors

New study identifies ways to detect COPD in low- and middle-income countries

Impact of post-exposure BNT162b2 prophylaxis against SARS-CoV-2 infections

Developing a 'fingerprint' test that could diagnose Alzheimer’s early

COVID-19 symptoms found to vary in different immune contexts

Ketamine plus psychological therapy can help people stay off alcohol for longer time

Secondhand nicotine vaping at home may increase risk of bronchitic symptoms in young adults

Psychotropic drugs are commonly used by patients with heart disease, study shows

Neurologist receives ERC grant to study novel light-activated drugs with antiepileptic effects

Poor cognition may be part of normality in older age, research says

Research may lead to new treatment options for Crohn's disease patients

Improving air quality may reduce dementia risk in older women

Researchers illuminate the molecular landscape and clinical features of rare kidney cancer

Higher olive oil consumption linked with lower risk of cardiovascular disease, cancer mortality

New grant program launches to advance therapeutic discovery for follicular lymphoma

NCCN publishes new guidelines for managing patients with Graft-Versus-Host Disease

Scientists shine new light on the complexity of vitamin B12 diseases

JPND announces call for multinational research on understanding the mechanisms of non-pharmacological interventions

Mapping regulatory T-cell populations in COVID-19 patients

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Latest News